Literature DB >> 31784690

Questions EMERGE as Biogen claims aducanumab turnaround.

Robert Howard1, Kathy Y Liu2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 31784690     DOI： 10.1038/s41582-019-0295-9

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  30 in total

1.  Simulating the outcome of amyloid treatments in Alzheimer's disease from imaging and clinical data.

Authors:  Clément Abi Nader; Nicholas Ayache; Giovanni B Frisoni; Philippe Robert; Marco Lorenzi
Journal:  Brain Commun       Date:  2021-04-28

Review 2.  The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease.

Authors:  Guillermo Oliver; Jonathan Kipnis; Gwendalyn J Randolph; Natasha L Harvey
Journal:  Cell       Date:  2020-07-23       Impact factor: 41.582

Review 3.  Can we learn lessons from the FDA's approval of aducanumab?

Authors:  Kathy Y Liu; Robert Howard
Journal:  Nat Rev Neurol       Date:  2021-09-17       Impact factor: 42.937

Review 4.  Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review.

Authors:  Hannah W Haddad; Garett W Malone; Nicholas J Comardelle; Arielle E Degueure; Salomon Poliwoda; Rachel J Kaye; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-07-28

5.  Informed consent, therapeutic misconception, and clinical trials for Alzheimer's disease.

Authors:  James M Wilkins; Brent P Forester
Journal:  Int J Geriatr Psychiatry       Date:  2020-01-26       Impact factor: 3.485

Review 6.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

7.  Genetic dependency of Alzheimer's disease-associated genes across cells and tissue types.

Authors:  Suraj K Jaladanki; Abdulkadir Elmas; Gabriel Santos Malave; Kuan-Lin Huang
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.996

8.  Development of a PET radioligand selective for cerebral amyloid angiopathy.

Authors:  Eric E Abrahamson; Jeffrey S Stehouwer; Alberto L Vazquez; Guo-Feng Huang; N Scott Mason; Brian J Lopresti; William E Klunk; Chester A Mathis; Milos D Ikonomovic
Journal:  Nucl Med Biol       Date:  2020-05-12       Impact factor: 2.408

Review 9.  The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.

Authors:  Heather H C Lau; Martin Ingelsson; Joel C Watts
Journal:  Acta Neuropathol       Date:  2020-08-02       Impact factor: 17.088

10.  Computational Investigation of Gantenerumab and Crenezumab Recognition of Aβ Fibrils in Alzheimer's Disease Brain Tissue.

Authors:  Yujie Chen; Guanghong Wei; Jun Zhao; Ruth Nussinov; Buyong Ma
Journal:  ACS Chem Neurosci       Date:  2020-10-09       Impact factor: 4.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.